Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kalvista Pharmaceuticals Inc

KALV
Current price
8.82 USD +0.38 USD (+4.50%)
Last closed 8.44 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 303 438 848 USD
Yield for 12 month +70.60 %
Week
Month
Year
KALV
21.11.2021 - 28.11.2021

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with unmet needs in the United States. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts. Address: 55 Cambridge Parkway, Cambridge, MA, United States, 02142

Analytics

WallStreet Target Price

20.8 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures KALV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -97 114 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -35.7 %
PEG Ratio
Return On Equity TTM -62.64 %
Wall Street Target Price 20.8 USD
Revenue TTM 3 824 000 USD
Book Value 4.07 USD
Revenue Per Share TTM 0.21 USD
Dividend Share
Quarterly Revenue Growth YOY 30.7 %
Dividend Yield
Gross Profit TTM -80 276 000 USD
Earnings Share -3.13 USD
Diluted Eps TTM -3.13 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics KALV

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KALV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:14
Payout Ratio
Last Split Date 22.11.2016
Dividend Date 22.11.2016

Stock Valuation KALV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 76.3323
Price Sales TTM 107.4168
Enterprise Value EBITDA -1.6668
Price Book MRQ 2.1778

Financials KALV

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators KALV

For 52 weeks

5 USD 11.45 USD
50 Day MA 8.67 USD
Shares Short Prior Month 4 139 810
200 Day MA 9.1 USD
Short Ratio 15.43
Shares Short 4 003 311
Short Percent 12.43 %